ArticleEmerging infectious diseases2023

Treatment of Mpox with Suspected Tecovirimat Resistance in Immunocompromised Patient, United States, 2022.

Caitlin A Contag et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.